BAKER BROS. ADVISORS LP

SEC Form 4 insider
Replimune Group, Inc. ($REPL), Kodiak Sciences Inc. ($KOD), MADRIGAL PHARMACEUTICALS, INC. ($MDGL)
5 theses · first seen Aug 11, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d333100%+3.9%+3.9%
3d55240%+3.0%-0.4%
1w55240%+1.4%-3.9%
1m333100%+4.6%+4.6%
3m000———
6m000———
1y000———

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$MDGLSEC Form 4bullish
Long 91,806 shares of MDGL
Bought 91,806 @ $381.49 avg · $35,023,032 · 2026-11-04

Form 4: BAKER BROS. ADVISORS LP bought MDGL

BAKER BROS. ADVISORS LP (Director at MADRIGAL PHARMACEUTICALS, INC.) reported an open-market purchase of 91,806 shares of MDGL at an average $381.49, roughly $35,023,032, in a Form 4 filed 2026-11-06.

At post $399.63Now $428.95+7.3% since postedas of Nov 9, 11:30 AM ET
1d—
3d+8.3%
1w+6.9%
1m—
3m—
6m—
1y—
View filing on SEC.gov →
$KODSEC Form 4bullish
BAKER BROS. ADVISORS LP · Kodiak Sciences Inc. · 8d ago4 prior · awaiting results
Long 247,090 shares of KOD
Bought 247,090 @ $98.51 avg · $24,340,836 · 2026-11-04

Form 4: BAKER BROS. ADVISORS LP bought KOD

BAKER BROS. ADVISORS LP (Director at Kodiak Sciences Inc.) reported an open-market purchase of 247,090 shares of KOD at an average $98.51, roughly $24,340,836, in a Form 4 filed 2026-11-06.

At post $99.30Now $111.19+12.0% since postedas of Nov 13, 4:01 PM ET
1d—
3d+7.9%
1w+12.0%
1m—
3m—
6m—
1y—
View filing on SEC.gov →
$KODSEC Form 4bullish
BAKER BROS. ADVISORS LP · Kodiak Sciences Inc. · 45d ago4 prior · awaiting results
Long 715,592 shares of KOD
Bought 715,592 @ $88.59 avg · $63,397,609 · 2026-09-28

Form 4: BAKER BROS. ADVISORS LP bought KOD

BAKER BROS. ADVISORS LP (Director at Kodiak Sciences Inc.) reported an open-market purchase of 715,592 shares of KOD at an average $88.59, roughly $63,397,609, in a Form 4 filed 2026-09-30.

At post $94.80Now $111.19+17.3% since postedas of Nov 13, 4:01 PM ET
1d+3.9%
3d-0.4%
1w-3.9%
1m+4.6%
3m—
6m—
1y—
View filing on SEC.gov →
$KODSEC Form 4bullish
BAKER BROS. ADVISORS LP · Kodiak Sciences Inc. · 45d ago4 prior · awaiting results
Long 418,323 shares of KOD
Bought 418,323 @ $83.58 avg · $34,963,077 · 2026-09-28

Form 4: BAKER BROS. ADVISORS LP bought KOD

BAKER BROS. ADVISORS LP (Director at Kodiak Sciences Inc.) reported an open-market purchase of 418,323 shares of KOD at an average $83.58, roughly $34,963,077, in a Form 4 filed 2026-09-30.

At post $94.80Now $111.19+17.3% since postedas of Nov 13, 4:01 PM ET
1d+3.9%
3d-0.4%
1w-3.9%
1m+4.6%
3m—
6m—
1y—
View filing on SEC.gov →
$KODSEC Form 4bullish
BAKER BROS. ADVISORS LP · Kodiak Sciences Inc. · 45d ago4 prior · awaiting results
Long 807,840 shares of KOD
Bought 807,840 @ $72.57 avg · $58,625,708 · 2026-09-28

Form 4: BAKER BROS. ADVISORS LP bought KOD

BAKER BROS. ADVISORS LP (Director at Kodiak Sciences Inc.) reported an open-market purchase of 807,840 shares of KOD at an average $72.57, roughly $58,625,708, in a Form 4 filed 2026-09-30.

At post $94.80Now $111.19+17.3% since postedas of Nov 13, 4:01 PM ET
1d+3.9%
3d-0.4%
1w-3.9%
1m+4.6%
3m—
6m—
1y—
View filing on SEC.gov →

End of results.